Hoth Therapeutics believes in following the science to identify the best application for a therapeutic rather by targeting indications with the biggest need and selecting the best route of delivery for patients. Our current assets have shown promise in a range of illnesses and diseases, including cancer, acne, inflammatory bowel disease, asthma, COVID-19, atopic dermatitis, skin toxicities associated with cancer therapy, chronic wounds, psoriasis, Alzheimer’s disease, and pneumonia.